Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy
The immune cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has received significant attention as a cancer therapeutic due to its ability to selectively trigger cancer cell apoptosis without causing toxicity in vivo. While TRAIL has demonstrated significant promise in preclin...
| Main Authors: | , , , , , |
|---|---|
| Other Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society (ACS),
2021-03-15T12:43:27Z.
|
| Subjects: | |
| Online Access: | Get fulltext |